[an error occurred while processing this directive]

Journal of Chinese Integrative Medicine ›› 2009, Vol. 7 ›› Issue (11): 1047-1051.doi: 10.3736/jcim20091105

• Original Clinical Research • Previous Articles     Next Articles

Efficacy of Shenyi Capsule combined with gemcitabine plus cisplatin in treatment of advanced esophageal cancer: A randomized controlled trial

Jing-yu Huanga,Yan Suna,Qing-xia Fana,Yu-qing Zhangb   

  1. a Department of Oncology, the Fist Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, Henan Province, China
    b School of Humanities, Henan University of Traditional Chinese Medicine, Zhengzhou 450008, Henan Province, China
  • Received:2009-07-13 Accepted:2009-09-26 Online:2009-11-20 Published:2009-11-15
  • Contact: Qing-xia Fan E-mail:FQXzz43@yahoo.com.cn

Background

In recent years, Shenyi Capsule has been proven to have certain anti-angiogenic effects, and to be effective to many cancers, but its effects on advanced esophageal cancer are scarcely studied.
Objective

To observe the effects of Shenyi Capsule combined with gemcitabine plus cisplatin (GP) regimen in treatment of advanced esophageal cancer.Design, setting, participants and interventions: Sixty inpatients with advanced esophageal cancer from Henan Tumor Hospital, and the Fist Affiliated Hospital of Zhengzhou University were included and randomly divided into treatment group and control group. There were 30 cases in each group. Patients in the treatment group were treated with Shenyi Capsule combined with GP regimen, and patients in the control group were treated with GP regimen alone.Main outcome measures: The total response rate was calculated. The level of vascular endothelial growth factor (VEGF), the chemotherapy side reaction and quality of life in the two groups were evaluated. The follow-up of survival time was conducted too.
Results

There was no significant difference in total response rate between the two groups (P=0.264). The levels of VEGF in the two groups were decreased as compared with that before the treatment. After treatment, the VEGF level in the treatment group was lower than that in the control group (P=0.002). The decline rates of white blood cell and blood platelet, and the incidence rate of nausea and vomiting in the treatment group were lower than those in the control group, and there were significant differences between the two groups (P=0.045, P=0.036, P=0.037). The quality of life of the patients in the treatment group was better than that in the control group (P=0.028), and one-year survival rate in the treatment group was higher than that in the control group (P=0.047).
Conclusion

Shenyi Capsule combined with GP regimen is feasible and safe in treatment of advanced esophageal cancer, and the effects are better than chemotherapy alone. It can improve the total response rate, and is effective in inhibiting new angiogenesis of esophageal cancer, reducing chemotherapy side reaction, and improving the patients’ quality of life and survival rates.

Key words: Shenyi Capsule, Chemotherapy, Esophageal cancer, Randomized controlled trial

Table 1

Clinical data in the two groups"

Clinical data Control group Treatment group
Cases (male/female) 30 (17/13) 30 (18/12)
Median age [(Q25, Q75), years] 52 (42, 74) 54 (45, 75)
Pathological type
Squamous cell carcinoma 26 25
Adenocarcinoma 4 5
Metastasis
Lung metastasis 13 12
Liver metastasis 7 6
Brain metastasis 1 2
Lymph node metastasis 9 10

Figure 1

Flow diagram of this randomized trial"

[1] Sun Y, Shi YK. Manual of medical oncology(2nd ed)[M]. Beijing: People's Medical Publishing House, 2007,( 2nd ed):467-469
孙燕, 石远凯 . 临床肿瘤内科手册[M]. 北京: 人民卫生出版社, 2007: 467-469
[2] Sun Y. Medical oncology[M]. Beijing: People's Medical Publishing House, 2003: 994
孙燕 . 内科肿瘤学[M]. 北京: 人民卫生出版社, 2003: 994
[3] Lin JJ, Zeng YJ, Ma ZL . Clinical significance of serum vascular endothelial growth factor in lung carcinoma[J]. You Jiang Yi Xue, 2005,33(2):116-117
林家进, 曾雅静, 马泽粦 . 肺癌患者血清血管内皮细胞生长因子水平检测的临床意义[J]. 右江医学, 2005,33(2):116-117
[4] Zhou JC. Practical medical oncology[M]. Beijing: People's Medical Publishing House, 2003: 33-35
周际昌 . 实用肿瘤内科学[M]. 北京: 人民卫生出版社, 2003: 33-35
[5] Kroep JR, Pinedo HM, Ginccone G, Van Bochove A, Peters GJ, .Van Groeningen CJ . Phase Ⅱ study of cisplatin preceding gemcitabine in patients with advanced oesophageal cancer[J]. Ann Oncol, 2004,15(2):230-235
doi: 10.1093/annonc/mdh063 pmid: 1476011412
[6] Urba SG, Chansky K, Vanveldhuien PJ , Pluenne, Southwest Oncology Group Study.ke RE, Benedetti JK, Macdonald JS, Abbruzzese JL.Gemcitabine and cisplatin for patients with metastatic or recurrent esophageal carcinoma: a Southwest Oncology Group Study[J]. Invest New Drugs, 2004,22(1):91-97
doi: 10.1023/B:DRUG.0000006179.20974.af
[7] Wang JS, Qin SK, Chen YX, Wang L, Liu XF, He ZM . Clinical study on qi deficiency patients with non-small cell lung cancer(NSCLC) treated by Shenyi capsule[J]. Lin Chuang Zhong Liu Xue Za Zhi, 2001,6(4):327-331
汪久生, 秦叔逵, 陈映霞, 王琳, 刘秀峰, 何泽明 . 参一胶囊联合化疗治疗非小细胞肺癌气虚证的临床研究[J]. 临床肿瘤学杂志, 2001,6(4):327-331
[8] Lu PC, Zhan Z, Zhou KF, Chen JW . Effects of ginseng and ginseng combined with TNF on tumor animal[J]. Nanjing Zhong Yi Yao Da Xue Xue Bao, 1997,13(60):344-346
陆平成, 詹臻, 周坤福, 陈建伟 . 人参及人参联合TNF对肿瘤动物的作用[J]. 南京中医药大学学报, 1997,13(60):344-346
[9] Liu JW, Chen JX, Yu LH, Tian YX, Cui XY, Yan Q, Fu L . Inhibitory effect of ginsenoside-Rg3 on lung metastasis of mouse melanoma transfected with ribonuclease inhibitor[J]. Zhonghua Zhong Liu Za Zhi, 2004,26(12):722-725
doi: 10.3760/j.issn:0253-3766.2004.12.005
刘基巍, 陈俊霞, 于丽华, 田余祥, 崔秀云, 燕秋, 富力 . 人参皂苷Rg3和核糖核酸因子转基因对小鼠黑色素瘤的抑制作用研究[J]. 中华肿瘤杂志, 2004,26(12):722-725
doi: 10.3760/j.issn:0253-3766.2004.12.005
[10] Hua HQ, Shen XK, Qin SK, Chen HY . Anti-invasion and anti-metastasis effects of ginsenoside Rg3 on the hepatocellular carcinoma cell line.[J]. Zhongguo Ai Zheng Za Zhi, 2005,15(4):326-330
华海清, 沈小昆, 秦叔逵, 陈惠英 .. 人参皂苷Rg3抗人肝癌细胞株侵袭和转移的实验研究[J]. 中国癌症杂志, 2005,15(4):326-330
[1] Jing-lin Shi, Wan-hong Miao. Effects of acupuncture on lactoferrin content in tears and tear secretion in patients suffering from dry eyes: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(9): 1003-1008.
[2] Ming T. Tan , Jian-ping Liu , Lixing Lao. Adequate application of quantitative and qualitative statistic analytic methods in acupuncture clinical trials. Journal of Chinese Integrative Medicine, 2012, 10(8): 847-852.
[3] Lu Yu, Shui-miao Lin, Ru-qian Zhou, Wei-jun Tang, Pin-xian Huang, Ying Dong, Jian Wang, Zhi-hua Yu, Jiu-lin Chen, Li Wei, San-li Xing, Hui-juan Cao, Hong-bin Zhao. Chinese herbal medicine for patients with mild to moderate Alzheimer disease based on syndrome differentiation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(7): 766-776.
[4] Peng Fu , Xue-qiang Huang, Ai-hong Yuan, Guang Yu, Xiao-bin Mei, Ruo-lan Cu. Effects of salvianolate combined with alprostadil and reduced glutathione on progression of chronic renal failure in patients with chronic kidney diseases: a long-term randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 641-646.
[5] Hui Luo, Jian-ping Liu, Qing Li. Methodological issues and suggestions for improvement in randomized controlled trials of Chinese herbal medicine for recurrent miscarriage. Journal of Chinese Integrative Medicine, 2012, 10(6): 604-614.
[6] Shui-qiu Deng, Xue-nong Ouyang, Zong-yang Yu, Xi-hu Dai, Xi Chen, Fang-zheng Fang, Wen-wu Wang, Zhi-zhen Liu. Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage ⅢB/Ⅳ non-small-cell lung cancer: a Randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 635-640.
[7] Ming-xing Zhao, Zhen-hua Dong, Zhong-hai Yu, Shi-yuan Xiao, Ya-ming Li . Effects of Ginkgo biloba extract in improving episodic memory of patients with mild cognitive impairment: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(6): 628-634.
[8] Ying-chun Miao , Jin-zhou Tian , Jing Shi , Min Mao. Effects of Chinese medicine for tonifying the kidney and resolving phlegm and blood stasis in treating patients with amnestic mild cognitive impairment: A randomized, double-blind and parallel-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 390-397.
[9] Xiao-hui Sun, Sheng Liu . External Chinese medical therapy for pain associated with hyperplastic disease of the breast: Study protocol of a randomized, double-blind, multicenter, controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(4): 384-389.
[10] Zhu Yan-feng, Luo Hai-ming, Deng Zhong-long, Fu De-yu, Yao Wang, Dai Jian. Effects of the Chinese patent medicine, Honghua Injection, on platelet glycoprotein Ⅱb/Ⅲa receptors in patients with acute coronary syndrome: a randomized controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(3): 318-323.
[11] Li Min, Yang Ming-hui, Liu Yi. Effects of Chinese herbal medicine Bushen Huoxue Granule on quality of life of patients with Parkinson disease: a randomized, double-blinded and placebo-controlled trial. Journal of Chinese Integrative Medicine, 2012, 10(3): 310-317.
[12] Paula de Sousa Fragoso Ana, de Sá Ferreira Arthur. Evaluation of the immediate effects of manual acupuncture on brachial bicep muscle function in healthy individuals and poststroke patients: a study protocol of a parallel-group randomized clinical trial. Journal of Chinese Integrative Medicine, 2012, 10(3): 303-309.
[13] Li-xin Ma, Yu-yi Wang, Xin-xue Li, Jian-ping Liu . Systematic review on methodology of randomized controlled trials of post-marketing Chinese patent drugs for treatment of type 2 diabetes. Journal of Chinese Integrative Medicine, 2012, 10(3): 279-292.
[14] Wang Yun-fei, Que Hua-fa, Xu Jie-nan, Tang Han-jun, Xiang Huan-yu, Liu Xiao-dong, Zhang Zhen, Xing Jie, Shen Liang, Shan Wei, Liu An-min, Qiu Lian-yin, Deng Da-yi, Gao Dan. Assessment of external methods of traditional Chinese medicine in patients with chronic ulcer of the lower extremities: study protocol of a multicenter, randomized, parallel-group, prospective trial. Journal of Chinese Integrative Medicine, 2012, 10(2): 166-175.
[15] Liu Jian, Gao Ying, Kan Bao-hong, Zhou Li. Systematic review and meta-analysis of randomized controlled trials of Chinese herbal medicine in treatment of multiple sclerosis. Journal of Chinese Integrative Medicine, 2012, 10(2): 141-153.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. An explanation on "guiding principles of clinical research on mild cognitive impairment (protocol)". Journal of Chinese Integrative Medicine, 2008, 6(1): 15-21
[2] Yi-ting He, Qing-lin Zha, Jian-ping Yu, Yong Tan, Cheng Lu, Ai-ping Lv. Principal factor analysis of symptoms of rheumatoid arthritis and their correlations with efficacy of traditional Chinese medicine and Western medicine. Journal of Chinese Integrative Medicine, 2008, 6(1): 32-36
[3] Jun Cai, Hua Wang, Sheng Zhou, Bin Wu, Hua-rong Song, Zheng-rong Xuan. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: A randomized controlled trial. Journal of Chinese Integrative Medicine, 2008, 6(1): 37-40
[4] Wei Zhang, Xiang-feng Lu, Xiao-mei Zhang, Jian-jun Wu, Liang-duo Jiang. A rat model of pulmonary fibrosis induced by infusing bleomycin quickly through tracheal intubation. Journal of Chinese Integrative Medicine, 2008, 6(1): 60-67
[5] A-gao Zhou, Yong Zhang, Gang Kui, De-Yun Kong, Hai-liang Ge, Qiu-hua Ren, Jia-rong Dong, Sheng Hong, Xu-ming Mao, Yin Wang, Hui-zheng Zhang, Shu-jun Wang. Influence of traditional Chinese compound recipes with different efficacy on body weight, tumor weight and immune function in H22 cancer-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 77-82
[6] Guo-hong Yuan, Xiao-jing Pang, He-chao Ma. Synergic effects of Danggui Buxue Decoction in reducing toxicity of cytoxan in tumor-bearing mice. Journal of Chinese Integrative Medicine, 2008, 6(1): 83-88
[7] Li Zhou, Hong-xing Zhang, Ling-guang Liu, Wen-jun Wan. Effect of electro-acupuncture at Fenglong (GV 16) on nitric oxide and endothelin in rats with hyperlipidemia. Journal of Chinese Integrative Medicine, 2008, 6(1): 89-92
[8] Jin-zhou Tian, Jing Shi, Xin-qing Zhang, Qi Bi, Xin Ma, Zhi-liang Wang, Xiao-bin Li, Shu-li Shen, Lin Li, Zhen-yun Wu, Li-yan Fang, Xiao-dong Zhao, Ying-chun Miao, Peng-wen Wang, Ying Ren, Jun-xiang Yin, Yong-yan Wang, Beijing United Study Group on MCI of the Capital Foundation of Medical Developments. Guiding principles of clinical research on mild cognitive impairment (protocol). Journal of Chinese Integrative Medicine, 2008, 6(1): 9-14
[9] Xin-jun Wang, Ling-ling Wang . A mechanism of endogenous opioid peptides for rapid onset of acupuncture effect in treatment of depression. Journal of Chinese Integrative Medicine, 2010, 8(11): 1014-1017
[10] Bo Wang , Wei Yan , Li-hui Hou, Xiao-ke Wu. Disorder of Tiangui (kidney essence) and reproductive dysfunction in patients with polycystic ovary syndrome. Journal of Chinese Integrative Medicine, 2010, 8(11): 1018-1022
[an error occurred while processing this directive]